Etoiles Capital Group (EFTY) shares climbed roughly 126% in the final 30 days of trading before their suspension, rising from $6.64 to $15.02. The surge followed an August 2025 initial public offering priced at $4.00 per share and was driven by extreme, low-float trading momentum rather than a single fundamental catalyst.
SPTM declined roughly 10% over the trailing 30 days, pulled lower by a technology-led correction across U.S. equities. The fund's information technology allocation — approximately 36% of assets — amplified losses as semiconductor and artificial-intelligence (AI) names sold off sharply.
EYPT fell roughly 45% over the last 30 days, declining from about $0.43 to near $0.23, extending a much larger multi-month selloff. The drop follows the failure of the LUCIA Phase 3 trial in wet AMD and a restructuring that cut roughly 53% of the workforce.
First Solar (FSLR) shares fell roughly 19.7% over the last 30 days, from about $171.25 to $137.59, as of late November 2026. The decline followed mixed third-quarter 2026 results: revenue fell 22.8% year over year to $1.23 billion and missed estimates, even as earnings per share of $5.30 beat expectations.
QQQP declined roughly 29% over the past 30 days as a sharp pullback in large-cap growth stocks was amplified by the fund's 2x quarterly leverage. The longer-term trend is equally weak, with QQQP down approximately 32% over the past three months.
DSGX traded near $89.21 at its latest close, down about 3.4% over the trailing 30 days after reaching a mid-November high around $96. Over the last quarter, the stock has gained roughly 14.6%, extending a broader multi-month uptrend.
Eversource Energy (ES) shares have climbed roughly 4.7% over the past 30 days, a modest, sub-10% move consistent with a defensive regulated utility. The broader quarter has been choppy: the stock slipped from near $72 in late August to a closing low near $63 in late September before recovering into the low $70s.
ProShares Ultra Technology (ROM) declined roughly 39% over the last 30 days , as its 2x daily leverage amplified a sharp pullback in large-cap U.S. technology stocks. The fund also fell approximately 36% over the trailing quarter , reflecting a broad repricing of the artificial intelligence (AI) trade rather than an isolated one-day event.
BITX fell roughly 50% over the last 30 days , reflecting a sharp, leverage-amplified decline in the price of bitcoin. The quarterly trend is also negative, with the fund down approximately 40% over the last three months after a late-summer rally gave way to persistent selling.
HUT shares fell roughly 36% over the past 30 days, closing at $45.95 on November 20, 2026, down from about $71.58 a month earlier. The decline extends a longer pullback, with the stock down approximately 48% over the trailing quarter.
DoorDash (DASH) shares declined roughly 17.9% over the last 30 days, closing near $152.60 in mid-November after trading near $186 a month earlier. The slide came despite record Q3 2026 results: revenue of $4.62 billion (up 33.95% year over year) and net income of $466 million (up 90.98%).
PMMR is an actively managed defined-outcome ETF (exchange-traded fund) that seeks to match the price return of the SPDR S&P 500 ETF Trust ( SPY ) up to a cap, while targeting a 100% downside buffer over a one-year outcome period. The fund is built with FLEX options — customized, exchange-traded option contracts — pairing purchased puts and written calls on SPY rather than holding individual equities.
JetBlue Airways (JBLU) rose roughly 25% over the past 30 days, climbing from a close of $2.65 on October 22, 2026, to $3.32 on November 20, 2026. The rebound followed third-quarter 2026 results showing 21.1% revenue growth and fourth-quarter unit-revenue guidance that came in above consensus expectations.
Medical Properties Trust (MPT) shares declined roughly 33% over the trailing 30 days, falling from about $2.63 to $1.75 per share. The slide extends a longer downtrend: the stock is down approximately 57% over the trailing quarter and has traded near 52-week lows.
MPLX LP units traded near $55.77 at the most recent close, roughly 4.6% below levels from 30 days earlier, within a relatively tight midstream trading range. The partnership raised its quarterly distribution by 12.5% for a third consecutive year, to $1.2111 per unit ($4.84 annualized), underscoring the durability of its fee-based cash flows.
Tilray Brands (TLRY) shares fell roughly 35.5% over the last 30 days, declining from about $2.93 on October 22, 2026, to $1.89 on November 20, 2026. The drop extends a broader downtrend, with the stock down roughly 61% over the last quarter from about $4.84 in late August 2026.
OFA Group (OFAL) shares fell roughly 40% over the last 30 days, extending a longer multi-month decline for the micro-cap architecture and digital-asset company. A 1-for-10 reverse stock split of Class A ordinary shares took effect in early November 2026, and the stock continued to slide in the sessions that followed.
CRDF shares declined roughly 8% over the trailing 30 days, weighed down by a licensing dispute and capital-structure concerns, before rebounding sharply on an FDA Fast Track designation for onvansertib. Cardiff Oncology is advancing onvansertib, a PLK1 inhibitor, through a randomized Phase 2 trial in first-line RAS-mutated metastatic colorectal cancer, with a registrational Phase 3 study in preparation.
TH International Limited (THCH) is the exclusive Tim Hortons master franchisee for mainland China, Hong Kong, and Macau, with shares trading near the $1.00 level. The stock has been largely rangebound over the past 30 days, moving between roughly $0.86 and $1.53 amid thin trading volume.
Both EFA and SCHF are passive, market-cap-weighted "foreign large blend" funds, but they track different indexes with meaningfully different country and sector exposures. SCHF tracks the FTSE Developed ex-US Index, which includes Canada and South Korea; EFA tracks the MSCI EAFE Index, which excludes both of those markets.
Previous
9 of 1954
Next